Holoclar
| Name | Holoclar |
|---|---|
| Active Substance | Ex vivo umnožene autologne epitelne stanice ljudske rožnice koje sadrže matične stanice |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| ATC Code | S01XA19 |
| Link to the European Medicines Agency's (EMA) product information | download |
| Educational materials for healthcare professionals |
Edukacijski priručnik za zdravstvene radnike, verzija 1 |
| Educational materials for patients / caregivers |
Informativni vodič za bolesnike, verzija 1 |
Note
The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/holoclar
The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm
